WILLIAM A. CARTER, M.D. - Corporate Board Profile

AIM ImmunoTech Inc.

Filing Date	Source Excerpt
2011-09-16	WILLIAM A. CARTER, M.D., 73, the co-inventor of Ampligen®, joined us in 1978, and has served as: (a) our Chief Scientific Officer since May 1989; (b) the Chairman of our Board of Directors since January 1992; (c) our Chief Executive Officer since July 1993; (d) our President since April, 1995; and (e) a director since 1987. ... Executive Committee is composed of Dr. William A. Carter, Chief Executive Officer and Chairman of the Board ... The Strategic Planning Committee is composed of Dr. William A. Carter, Dr. William M. Mitchell, and Thomas K. Equels. ... Director Compensation - 2010 ... W. Carter, Chairman & Chief Executive Officer ... Total ($) 1,911,340
2012-08-23	William A. Carter, M.D., 74, the co-inventor of Ampligen®, joined us in 1978, and has served as: (a) our Chief Scientific Officer since May 1989; (b) the Chairman of our Board of Directors since January 1992; (c) our Chief Executive Officer since July 1993; (d) our President from April 1995 to November 2006 and then again December 2011 to present; and (e) a Director since 1987. ... Our Compensation, Audit and Corporate Governance and Nomination Committees, consist of Dr. Iraj E. Kiani, Compensation Committee Chair, Dr. William M. Mitchell, Corporate Governance and Nomination Committee Chair, and Richard C. Piani, Audit Committee Chair, all of whom are independent Board of Director members. ... The Executive Committee is composed of Dr. William A. Carter, Chief Executive Officer and Chairman of the Board, Dr. William M. Mitchell, Director, and Thomas K. Equels, Executive Vice Chairman of the Board, Secretary and General Counsel. ... The Strategic Planning Committee is composed of Dr. William A. Carter, Dr. William M. Mitchell, and Thomas K. Equels. ... Director Compensation - 2011 ... W. Carter, Chairman, Chief Executive Officer, President & Chief Scientific Officer ... Total: $1,517,065.
2013-09-16	William A. Carter, M.D., 75, the co-inventor of Ampligen®, joined us in 1978, and has served as: (a) our Chief Scientific Officer since May 1989; (b) the Chairman of our Board of Directors since January 1992; (c) our Chief Executive Officer since July 1993; (d) our President from April 1995 to November 2006 and then again December 2011 to present; and (e) a Director since 1987. ... The Compensation Committee in light of pre-established individual, along with position appropriate Company-wide goals (A. through O. as disclosed above) and objectives, undertook a weighted-average evaluation of the performance of each key executive in order to determine respective annual incentive opportunities considering base salary and fees, short and long-term incentive opportunity and any special/supplemental benefits or payments. Based upon all of the foregoing, the Committee determined that the following 2012 Performance Bonuses were granted and paid in 2012 to the following NEO at the rate of 25% of their respective 2012 year-end base compensation: William Carter (Chairman, CEO, President, Chief Scientific Officer) for $241,906; ... The following table provides information on the compensation during the fiscal years ended December 31, 2012, 2011 and 2010 of our Chief Executive Officer, Chief Financial Officers, three other most highly compensated Executive Officers and two mostly highly compensated non-executives, constituting the Company’s Named Executive Officers, based on the year-ending 2012 for each fiscal year. ... Summary Compensation Table ... William A. Carter CEO, President & CSO 2012 Salary/Fees $1,143,692 Bonus $1,401,099 All Other Compensation $282,565 Total $2,827,356 ... In June 2012, each Director was granted an Option to purchase 100,000 shares of Company common stock with an exercise price equal to 110% of the final closing price of the Company's common stock on the NYSE MKT LLC as of June 5, 2012 ($0.26), that will vest one year after issuance, contain a cashless exercise provision, have a ten year term and were issued from the Company's 2009 Equity Incentive Plan.
2014-10-10	W. Carter, Chairman - Director Compensation - 2013 - Fees Earned or Paid in Cash: 179,766; Option Awards: 28,515; Total: 208,281
2015-07-07	Dr. William A. Carter, Hemispherx’s Chief Executive Officer, received approximately $182,000 for 2014 as Board fees. Director Compensation - 2014 table shows $182,462 fees earned or paid in cash and total $202,161. He is Chairman of the Board, CEO, President and Chief Scientific Officer.
2015-08-10	For his Board fees, Dr. William A. Carter, Hemispherx’s Chief Executive Officer, received approximately $182,000 for 2014. Director Compensation - 2014 table shows W. Carter, Chairman, 182,462 fees earned or paid in cash and total 202,161.